Home

THE ONLY FDA-APPROVED AND LABELED ACE INHIBITOR TREATMENT FOR PEDIATRIC HYPERTENSION IN PATIENTS OLDER THAN 1 MONTH

  • Trusted efficacy delivered with consistent potency.1
  • User-friendly solution provides everything needed for preparation.1
  • Oral solution provides consistent stability when stored as directed.1
  • Robust coverage and reimbursement support.

References: 1. Epaned [prescribing information]. Greenwood Village, CO: Silvergate Pharmaceuticals, Inc.; 2016.

The information in this section is intended for healthcare providers in the United States.

I certify that I am a healthcare provider in the United States.